Systematic review and network meta-analysis of approved medicines for the treatment of idiopathic pulmonary fibrosis

Background: Clinical practice guidelines for the treatment of idiopathic pulmonary fibrosis (IPF) currently recommend pirfenidone and nintedanib. However, there is a lack of evidence from head-to-head comparisons. Objectives: To perform a systematic review and network meta-analysis (NMA) to access t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Drug Assess
Hlavní autoři: Skandamis, Aristeidis, Kani, Chara, Markantonis, Sophia L., Souliotis, Kyriakos
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2019
Témata:
Respiratory Medicine
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6484486/
https://ncbi.nlm.nih.gov/pubmed/31044096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21556660.2019.1597726
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky